Katja Pinker-Domenig, MD, PhD
Radiologist
Titles
Director of Research; Director of Breast MRI, Breast Imaging Service, Department of Radiology.
Clinical Expertise
Breast and Body Imaging
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Pinker-Domenig accepts the following list of insurance providers. Select your insurance provider to see more details.
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO, DSN
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO EPO
Payor Type: Commercial
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): Federal Government
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP
Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): TBD
Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO
Payor Type: Commercial
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Contact and Location
- Speaks English and German
- Evelyn H. Lauder Breast Center New York, NY
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
See all locationsAbout Me
Education
MD, Medical University of Vienna; PhD, Medical University of Vienna
Residencies
Radiology - Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna (Austria)
Fellowships
Division of Breast and Gender Imaging - Medical University of Vienna (Austria)
Board Certifications
Radiology (Austria)
I am a radiologist with subspecialty expertise in breast and oncologic imaging, disease management teamwork, and research in advanced medical imaging. Before joining Memorial Sloan Kettering Cancer Center (MSK), I trained and practiced at the Medical University of Vienna in Austria for almost a decade. Due to my strong interest in cancer research that uses advanced imaging, I chose to join MSK in 2014 as a researcher.
I am proud to have been a part of the research community at MSK and the radiology team at Memorial Hospital since November 2017, as well as a professor of radiology at Weill Medical College of Cornell University since November 2020. I currently serve as the Director of Research and the Director of Breast MRI for the Breast Imaging Service in MSK’s Department of Radiology.
Read more
I have extensive expertise in all aspects of state-of-the-art breast imaging, including mammography, digital breast tomosynthesis, ultrasound, and MRI. Additionally, I am experienced in breast interventions.
One of my top clinical accomplishments is successfully using multiparametric MRIs (which give more detailed pictures) in routine patient care. This is a concept that I developed, investigated, and implemented in Vienna and further refined at MSK in order to achieve the most accurate breast cancer detection.
My goal is to promote the quality of clinical breast imaging worldwide. As such, I serve as an Executive Board Member for the nonprofit European Society of Breast Imaging. I also have co-authored several guidelines addressing all aspects of breast cancer imaging and am actively involved in the development of consensus and mission statements published in distinguished journals such as The Lancet Oncology.
I have earned an international reputation for cutting-edge research in breast imaging. My research, which has largely been funded by external sources (or extramural funding), has continued to advance scientific knowledge and clinical practice. My research interests focus on molecular breast imaging with advanced high-field/ultra-high-field MRI using multiple advanced MRI parameters and hybrid (combined) techniques, such as positron emission tomography (PET)-MRI with specific tracers and the application of AI in oncologic imaging. I aim to develop new imaging biomarkers in breast cancer so that they can be used to improve diagnosis, prediction, and prognosis in the clinical care setting. A special focus is to investigate multiparametric (which takes different types of pictures), multimodal (which combines techniques) imaging as a noninvasive tool to better understand the effectiveness and early response assessment of therapy, thus improving treatment interventions. I have published more than 200 peer-reviewed papers in breast and oncologic imaging.
I serve on several editorial boards for publications including BJR Open (as Editor-In-Chief) and the Journal of Magnetic Resonance Imaging (as Deputy Editor). I am active in many committees with international organizations, including the American College of Radiology, European Society of Breast Imaging, and European Society of Radiology, International Society for Magnetic Resonance in Medicine, and Radiological Society of America.
I am also a popular teacher at national and international conferences, where I have served as organizer, peer reviewer, and chairperson. In recognition of my accomplishments, I have been named a Fellow of the International Society for Magnetic Resonance in Medicine.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Pinker-Domenig’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Katja Pinker-Domenig discloses the following relationships and financial interests:
-
AURA Health Technologies GmbH
Provision of Services -
European Society of Breast Imaging (EUSOBI)
Provision of Services
-
MX Healthcare GmbH
Ownership / Equity Interests; Provision of Services (uncompensated)
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
